Clinical Trials on Transformed Non-Hodgkin Lymphoma
Total 5327 results
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
SanofiCompleted
-
Oncology Specialists, S.C.CompletedNon-Hodgkin's Lymphoma
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Australia, Canada
-
Scotland and Newcastle Lymphoma GroupUnknown
-
Commissie Voor Klinisch Toegepast OnderzoekUnknown
-
BiogenCompletedNon-Hodgkin's LymphomaUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed
-
BiogenCompletedNon-Hodgkin's LymphomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital; University of Rochester and other collaboratorsCompletedNon-Hodgkin's LymphomaUnited States
-
Biotec Pharmacon ASACompletedNon-Hodgkin's LymphomaNorway
-
Genitope CorporationTerminated
-
AmgenCompletedNon-Hodgkin's Lymphoma
-
Pharmacyclics LLC.CompletedLymphoma | Non-Hodgkin's LymphomaUnited States
-
Corixa CorporationGlaxoSmithKlineUnknownNon-Hodgkin's LymphomaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHodgkin Lymphoma | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | AML | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloproliferative Disorder | ALL | Non-malignant Diseases Requiring Allogeneic HSCTUnited States
-
German High-Grade Non-Hodgkin's Lymphoma Study...UnknownLymphoma | Long-term Effects Secondary to Cancer Therapy in Adults
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsTerminatedNon-Hodgkin's LymphomaUnited States
-
David Bond, MDRecruitingRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedChronic Lymphocytic Leukaemia (CLL) | Multiple Myeloma (MM) | B-Cell Non-Hodgkin Lymphoma (NHL)France, Australia, Germany, Korea, Republic of, United Kingdom, Hungary, Poland, Singapore
-
Hoffmann-La RocheRecruitingNon-Hodgkin LymphomaUnited States, Israel, Italy, Spain, United Kingdom
-
BayerActive, not recruitingLymphoma,Non-HodgkinChina, Hong Kong, Spain, Taiwan, Turkey, Japan, Russian Federation, Singapore, France, Austria, Bulgaria, Korea, Republic of, Malaysia, Thailand, United States, Hungary, Italy, Poland, Portugal, Germany, Mexico, Romania, Australia, Uk... and more
-
Mayo ClinicRecruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Institute of Hematology & Blood Diseases HospitalShanghai Cell Therapy Engineering Technology Research Center Group Co., Ltd.UnknownDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Transformed LymphomaChina
-
The Affiliated Hospital of Xuzhou Medical UniversityRecruitingB-cell Non Hodgkin LymphomaChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingB-cell Non Hodgkin LymphomaChina
-
Hebei Yanda Ludaopei HospitalGracell Biotechnology Ltd.UnknownB-cell Non Hodgkin LymphomaChina
-
Marcela V. Maus, M.D.,Ph.D.RecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Non-hodgkin Lymphoma | High-grade B-cell Lymphoma | Grade 3b Follicular Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin Disease | Peripheral T Cell LymphomaUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingFollicular Lymphoma | Non-Hodgkin's Lymphoma | NHLUnited States
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.Active, not recruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaChina
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
PfizerUCB PharmaCompletedB-Cell LymphomaUnited States, Belgium, Korea, Republic of, Switzerland, France, Poland, Spain, Hong Kong, Australia, Germany, Italy, Netherlands, United Kingdom
-
Hoosier Cancer Research NetworkGenentech, Inc.; Millennium Pharmaceuticals, Inc.TerminatedLymphoma, Non-HodgkinUnited States
-
Acrotech Biopharma Inc.Withdrawn
-
Assistance Publique - Hôpitaux de ParisCompletedGlioma | Non Small Cell Lung Cancer | Non Hodgkin LymphomaFrance
-
Grupo Argentino de Tratamiento de la Leucemia AgudaRecruitingLymphoma, Non-Hodgkin's, AdultArgentina
-
Xinqiao Hospital of ChongqingChongqing Precision Biotech Co., LtdNot yet recruiting
-
New Mexico Cancer Care AllianceTerminatedCancer | Non-Hodgkin's LymphomaUnited States
-
SystemixNational Cancer Institute (NCI)Unknown
-
AmgenUnknown
-
Cancer Research Campaign Clinical Trials CentreCompleted
-
BayerCompletedNon-Hodgkin's Lymphoma (NHL)Japan
-
MedImmune LLCTerminatedLymphomaUnited States, Poland
-
Adnexus, A Bristol-Myers Squibb R&D CompanyCompletedCancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Refractory Plasma Cell Myeloma | Recurrent Histiocytic and Dendritic Cell Neoplasm | Recurrent Non-Hodgkin Lymphoma | Refractory Histiocytic and Dendritic Cell Neoplasm | Refractory Non-Hodgkin Lymphoma | Recurrent Plasma Cell MyelomaUnited States
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieCompletedUnresectable Solid Neoplasm | Recurrent Solid Neoplasm | Refractory Mantle Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Advanced Solid Neoplasm | T-Cell Non-Hodgkin LymphomaUnited States
-
BayerCompletedMedical OncologyCanada, United States
-
National Cancer Institute (NCI)TerminatedLymphoma | Solid TumorsUnited States